ILMN Illumina, Inc.
$206.45▲ +2.57%
Healthcare
Other
After hours
$207.72▲ +0.61%
Sep 11, 7:43 PM ET
Volume 2.41M
Avg Volume (10D) 1.73M
Key Metrics & Fundamentals
Market Cap
$31.17B
P/E Ratio
38.6
Div Yield
–%
52W Range
88.00 - 231.81
% vs 50 MA
0.71%
% vs 200 MA
31.42%
RSI-14
45.6
MACD Histogram
-2.2800
Beta (1Y vs SPY)
0.86
Free Cash Flow
$251.00M
Gross Rev
$1.09B
Gross Profit
$721.00M
EBITDA
$250.00M
COGS
$370.00M
Operating Exp
$512.00M
Operating Income
$209.00M
EBIT
$209.00M
Pretax Income
$157.00M
Net Income
$134.00M
EPS (Diluted)
0.87
Price & Volume History
Loading chart…
Recent News
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
GlobeNewswire · Sep 10, 2026 11:03 AM
S&P Dow Jones Indices CEO on Index Restructuring
Bloomberg · Sep 9, 2026 8:34 PM
Dear Illumina Stock Fans, Mark Your Calendars for September 21
Barchart · Sep 9, 2026 2:32 PM
Dear Everpure Stock Fans, Mark Your Calendars for September 21
Barchart · Sep 9, 2026 2:10 PM
UBS Upgrades Illumina to Buy From Neutral, Adjusts Price Target to $260 From $135
MT Newswires · Sep 9, 2026 1:20 PM
Encoded Therapeutics Raises $275 Million in Series F Financing to Advance ETX101 Through Pivotal Development and Accelerate its Precision Genetic Medicines Neurology Pipeline
Business Wire · Sep 9, 2026 12:30 PM
3 Stocks Soon Joining the S&P 500
Zacks · Sep 9, 2026 12:38 AM
ILMN Stock Keeps Climbing. Should You Climb On?
Trefis · Sep 8, 2026 7:37 PM
3 Promising Genomics Stocks in the Spotlight in 2026
Zacks · Sep 8, 2026 4:46 PM
Multiomics Market Report Now Available — See Why Spatial Omics Is Set to Outgrow Single-Cell as the Field's Next Growth Driver
GlobeNewswire · Sep 8, 2026 3:51 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See ILMN's money flow as a full page
Social Sentiment
Avg +0.66 · 7 posts
DDNewsDiscussion$TXG: The picks and shovels trade of biotech AI
r/wallstreetbets · Jul 15, 2026
Discusses ILMN as one of the top companies to invest in due to their innovation labs.
positive
+0.60
NewsDiscussionWhat if the next AI is genetics?
r/StockMarket · Jun 2, 2026
The post discusses ILMN’s role in sequencing technologies, a key component of gene editing, indicating a positive view.
positive
+0.70
NewsDiscussionWhat if the next AI is genetics?
r/stocks · Jun 2, 2026
ILMN's role in sequencing technologies is central to the post's narrative.
positive
+0.80
NewsDiscussionTrade$ILMN may be one of the strangest Trump–Xi summit trades hiding in plain sight
r/wallstreetbets · May 14, 2026
The post frames Illumina's inclusion as a strategic move due to a geopolitical issue, implying potential future business opportunities.
positive
+0.60
Grail (GRAL) and the Future of Early Cancer Detection: A Data-Driven Perspective
r/stocks · Feb 17, 2025
The post expresses optimism about ILMN's future and highlights the company's strong financials and technology, indicating a positive sentiment.
positive
+0.60
Page 1 of 2 (7 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.